4Cisneros JM, Reyes MJ, Pachon J, et al.Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features[J].Clin Infect Dis, 1996, 22(6): 1026-1032.
5Rodriguez BJ, Pascual A, Galvez J, et al.Acinetobacter baumannii bacteremia: clinical and prognostic features[J].Enferm Infect Microbiol Clin, 2003, 21(5): 242-247.
6Ayan M, Durmaz R, Aktas E, et al.Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital[J].J Hosp Infect, 2003, 54(1): 39-45.
7Donald HM, Scaife W, Amyes SG, et al.Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92[J].Antimicrob Agents Chemother, 2000, 44(1): 196-199.
8Husni RN,Goldstein LS, Arroliga AC,et al. Risk factors for an outbreak of multi - drug - resistant acinetobacter nosoccmial pneumonia amgng intubated patients see comments[J].Chest, 1999,115(5) :1378- 1382.
9National Committee for Clinieal Laboratory Standards. Perfornance stardards for antimicrobial susceptibility testing [S].Ninth information Standard. M100-s9. Wayne,Pennsylvania:NCCLS, 1999. 100-102.
10National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. Fourth Edition. Approved Standard NCCLS Document. MT-A4. Wayne, PA: NCCLS, 1997.17.
8KARAGEORGOPOULOS D E, FALAGAS M E. Current control and treatment of mulfidrug-resistant Acinetobacter baumannil infections[ J]. Lancet Infect Dis,2008,8 (12) :751-762.
9SAKOULAS G, MOELLERING R C Jr. Increasing antibiotic resistance among methiciUin-resistant Staphylococcus aureus strains[ J]. Clin Infect Dis,2008,46 ( Suppl 5 ) :S360-3367.
